Difference between revisions of "TMPD"
From Bioblast
Line 8: | Line 8: | ||
== Application in [[HRR]] == | == Application in [[HRR]] == | ||
::: '''TMPD''' (C<sub>10</sub>H<sub>16</sub>N<sub>2</sub>*2HCl): Sigma T 3134, 5 g, store at RT; M = 237.2 g·mol<sup>-1</sup>. | ::: '''TMPD''' (C<sub>10</sub>H<sub>16</sub>N<sub>2</sub>*2HCl): Sigma T 3134, 5 g, store at RT; M = 237.2 g·mol<sup>-1</sup>. | ||
:::: <span style="color:#8B008B"> '''Caution:''' Sensitive to | :::: <span style="color:#8B008B"> '''Caution:''' Sensitive to light and oxidation (store solution in a dark vials). Take care to minimize light, oxygen and temperature exposure during use!</span> | ||
::::''' Complex IV assay ''': For the [[Complex_IV#HRR_protocol:_Complex_IV_assay|Complex IV assay]] TMPD is required at 0.5 mM final concentration added from a 200 mM stock. | ::::''' Complex IV assay''': For the [[Complex_IV#HRR_protocol:_Complex_IV_assay|Complex IV assay]] TMPD is required at 0.5 mM final concentration added from a 200 mM stock. | ||
:::: During the respirometry experiment it is important to add [[Ascorbate]] into the chamber shortly before TMPD to avoid uncontrolled autoxidation. Ascorbate maintains TMPD in a reduced state, and electrons flow from TMPD to cytochrome ''c''. For preparation and titration please visit [[Ascorbate]]. | :::: During the respirometry experiment it is important to add [[Ascorbate]] into the chamber shortly before TMPD to avoid uncontrolled autoxidation. Ascorbate maintains TMPD in a reduced state, and electrons flow from TMPD to cytochrome ''c''. For preparation and titration please visit [[Ascorbate]]. | ||
:::: 2021-03: The preparation instructions were updated to take the volume of the solute ( | :::: 2021-03: The preparation instructions were updated to take the volume of the solute (TMPD) into account (see: [[Volume_of_the_solute]]). | ||
Line 30: | Line 30: | ||
::::''' Preparation of 250 mM stock solution''' (dissolved in H<sub>2</sub>O) for '''0.5-mL O2k-chamber''': | ::::''' Preparation of 250 mM stock solution''' (dissolved in H<sub>2</sub>O) for '''0.5-mL O2k-chamber''': | ||
::::# Weigh 59 | ::::# Weigh 59.25 mg TMPD | ||
::::# Dissolve in 962 µL H<sub>2</sub>O | ::::# Dissolve in 962 µL H<sub>2</sub>O | ||
::::# Divide into 0.2 mL portions in dark vials | ::::# Divide into 0.2 mL portions in dark vials |
Revision as of 16:54, 7 April 2021
Description
N,N,N',N'-Tetramethyl-p-phenylenediamine dihydrochloride, TMPD, is applied as an artificial substrate for reducing cytochrome c in the respirometric assay for cytochrome c oxidase (CIV) activity. It is maintained in a reduced state by ascorbate and undergoes autoxidation as a function of oxygen pressure, TMPD, ascorbate and cytochrome c concentration.
Abbreviation: Tm
Reference: MiPNet06.06, MiPNet09.12
Application in HRR
- TMPD (C10H16N2*2HCl): Sigma T 3134, 5 g, store at RT; M = 237.2 g·mol-1.
- Caution: Sensitive to light and oxidation (store solution in a dark vials). Take care to minimize light, oxygen and temperature exposure during use!
- Complex IV assay: For the Complex IV assay TMPD is required at 0.5 mM final concentration added from a 200 mM stock.
- TMPD (C10H16N2*2HCl): Sigma T 3134, 5 g, store at RT; M = 237.2 g·mol-1.
- 2021-03: The preparation instructions were updated to take the volume of the solute (TMPD) into account (see: Volume_of_the_solute).
- Preparation of 200 mM stock solution (1 mL, dissolved in H2O) for 2-mL O2k-chamber:
- Weigh 47.4 mg TMPD
- Dissolve in 970 µL H2O
- Divide into 0.2 mL portions in dark vials
- Store frozen at -20 °C
- Preparation of 200 mM stock solution (1 mL, dissolved in H2O) for 2-mL O2k-chamber:
- » O2k manual titrations MiPNet09.12 O2k-Titrations
- Titration volume (2-mL O2k-chamber): 5 µL using a 25 µL Hamilton syringe.
- Final concentration: 0.5 mM.
- Preparation of 250 mM stock solution (dissolved in H2O) for 0.5-mL O2k-chamber:
- Weigh 59.25 mg TMPD
- Dissolve in 962 µL H2O
- Divide into 0.2 mL portions in dark vials
- Store frozen at -20 °C
- » O2k manual titrations MiPNet09.12 O2k-Titrations
- Titration volume (0.5-mL O2k-chamber): 1 µL using a 10 µL Hamilton syringe.
- Final concentration: 0.5 mM.
MitoPedia topics: Substrate and metabolite